About Avik Pharmaceuticals
Avik Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1980 by Anant Thakore. It manufactures corticosteroids and steroid APIs for pharmaceutical industry. It operates on a B2B model. The company has 174 employees. Its chief executive, as recorded, is Anant Thakore. Its Indian entity Avik Pharmaceutical Limited reported revenue of ₹103 Cr. Avik Pharmaceuticals offers products and services including Beclomethasone Dipropionate, Betamethasone Dipropionate, Budesonide, Clobetasol 17 Propionate, and Testosterone. Its focus areas include Pharmaceuticals, API Manufacturing, Steroids and Hormones. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Avik Pharmaceutical Limited is an RD-based company specializing in the production of active pharmaceutical ingredients, primarily corticosteroids, since the 1980s. It operates manufacturing facilities in Vapi, Gujarat, near Mumbai, India, focusing on steroids and hormones. The company supplies these products to various pharmaceutical entities, emphasizing quality and innovation in API development.
- Headquarters Mumbai, India
- Employees 174
- Founders Anant Thakore
- SectorsHealthcare
- Website avikpharma.com
- Legal Name Avik Pharmaceutical Limited
- Date of Incorporation 25 Sep, 1979
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹103 Cr
FY 2025 · +29% YoY
- Net Profit₹15.58 Cr
FY 2025 · 15% margin
- EBITDA₹24.95 Cr
FY 2025 · 24% margin
- Employee Count174
Associated legal entities of Avik Pharmaceuticals
Avik Pharmaceuticals operates through Avik Pharmaceutical Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avik Pharmaceutical Limited CIN U99999MH1979PLC021711 | Active | 25 Sep 1979 | Mumbai, Maharashtra | ₹103 Cr | 174 | 7 | View details |
Products & Services of Avik Pharmaceuticals
Avik Pharmaceuticals offers a comprehensive portfolio of products and services, including Beclomethasone Dipropionate, Betamethasone Dipropionate, Budesonide, Clobetasol 17 Propionate, and Testosterone.
Corticosteroid API used in respiratory treatments.
Anti-inflammatory steroid for skin conditions.
Corticosteroid for asthma and allergy management.
Topical steroid for severe skin inflammation.
Steroidal hormone for medical hormone therapy.
Progestin used in contraceptives and treatments.
Board of directors of Avik Pharmaceutical Limited (Avik Pharmaceuticals)
Avik Pharmaceutical Limited is the primary company behind Avik Pharmaceuticals. The board of Avik Pharmaceutical Limited currently have 6 directors; the longest-serving is Anant Rajendralal Thakore, appointed in 1979. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anant Rajendralal Thakore DIN 00095066 | Managing Director | 25 Sep 1979 | 47 yrs 1 mo | Avik Pharmaceutical Limited |
| Jeevan Lal Nagori DIN 00017939 | Director | 18 Nov 2013 | 12 yrs 11 mo | Avik Pharmaceutical Limited |
| Neha Anant Thakore DIN 00893957 | Whole-time director | 04 Jan 2022 | 4 yrs 9 mo | Avik Pharmaceutical Limited |
| Raj Kamal Prasad Verma DIN 02166789 | Director | 16 Sep 2024 | 2 yrs 1 mo | Avik Pharmaceutical Limited |
| Sushil Kumar Kumra DIN 08676523 | Director | 16 Sep 2024 | 2 yrs 1 mo | Avik Pharmaceutical Limited |
| Rajeshree Maruti Chougule DIN 10647042 | Company Secretary | 19 Dec 2024 | 1 yr 10 mo | Avik Pharmaceutical Limited |
People of Avik Pharmaceuticals
1 people are tracked at Avik Pharmaceuticals (1 in leadership); the tracked headcount is 174.
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership |
Complete people profiles for Avik Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Avik Pharmaceuticals
Figures of Avik Pharmaceutical Limited, the primary company behind Avik Pharmaceuticals, for FY 2025. Revenue was ₹103 Cr (+29% year on year). Net profit was ₹15.58 Cr (15% margin). EBITDA was ₹24.95 Cr (24% margin). Revenue has grown at a compounded annual rate of +17% over three years.
- ₹103 CrRevenue · FY 2025 · +29% YoY
- ₹15.58 CrNet profit · 15% margin
- ₹24.95 CrEBITDA · 24% margin
- ₹10.88 CrPaid-up capital
- 174Employees (provident fund records)
- +17%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Avik Pharmaceutical Limited are on its company page.
Detailed financial statements for Avik Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Avik Pharmaceuticals
Avik Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Avik Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avik Pharmaceuticals
The website of Avik Pharmaceuticals (avikpharma.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 280% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avik Pharmaceuticals
Avik Pharmaceuticals was founded in 1980.
Avik Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anant Thakore is the CEO of Avik Pharmaceuticals, as recorded in our data. They have also founded this company.
Avik Pharmaceuticals has 174 employees.
The primary company behind Avik Pharmaceuticals, Avik Pharmaceutical Limited, reported revenue of ₹103 Cr for FY 2025, up 29% year on year.
Avik Pharmaceutical Limited is an RD-based company specializing in the production of active pharmaceutical ingredients, primarily corticosteroids, since the 1980s. It operates manufacturing facilities in Vapi, Gujarat, near Mumbai, India, focusing on steroids and hormones. The company supplies these products to various pharmaceutical entities, emphasizing quality and innovation in API development.
Avik Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Avik Pharmaceuticals offers Beclomethasone Dipropionate, Betamethasone Dipropionate, Budesonide, Clobetasol 17 Propionate, and 2 more products and services.
Avik Pharmaceuticals operates through Avik Pharmaceutical Limited.
The legal entities of Avik Pharmaceuticals currently have 7 directors, including Jeevan Lal Nagori, Anant Rajendralal Thakore, Neha Anant Thakore and others.